What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. We’re focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world.
Oui — Editas Medicine a actuellement 3 offres ouvertes sur JobsRadar. 1 d’entre elles ont été publiées ces 30 derniers jours. Dernière mise à jour le 7 septembre 2026 à 10:02 UTC.